Business Description
InVivo Therapeutics Holdings Corp
NAICS : 325411
SIC : 2836
ISIN : US46186M4078
Description
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.38 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 80.2 | |||||
| 3-Year EPS without NRI Growth Rate | 79.8 | |||||
| 3-Year FCF Growth Rate | 79.4 | |||||
| 3-Year Book Growth Rate | -70.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.03 | |||||
| 9-Day RSI | 69.96 | |||||
| 14-Day RSI | 62.35 | |||||
| 6-1 Month Momentum % | -77.15 | |||||
| 12-1 Month Momentum % | -84.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | |||||
| Quick Ratio | 14.3 | |||||
| Cash Ratio | 12.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -379.5 | |||||
| Shareholder Yield % | 29.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -77.97 | |||||
| ROA % | -65.92 | |||||
| ROIC % | -534.26 | |||||
| ROC (Joel Greenblatt) % | -941 | |||||
| ROCE % | -79.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.13 | |||||
| Price-to-Tangible-Book | 0.13 | |||||
| EV-to-EBIT | 0.76 | |||||
| EV-to-EBITDA | 0.79 | |||||
| EV-to-FCF | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 0.13 | |||||
| Price-to-Net-Cash | 0.15 | |||||
| Earnings Yield (Greenblatt) % | 131.58 | |||||
| FCF Yield % | -885.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NVIVQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InVivo Therapeutics Holdings Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.29 | ||
| Beta | -0.33 | ||
| Volatility % | 72.04 | ||
| 14-Day RSI | 62.35 | ||
| 14-Day ATR ($) | 0.028808 | ||
| 20-Day SMA ($) | 0.328637 | ||
| 12-1 Month Momentum % | -84.43 | ||
| 52-Week Range ($) | 0.15 - 1.64 | ||
| Shares Outstanding (Mil) | 3.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InVivo Therapeutics Holdings Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InVivo Therapeutics Holdings Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
InVivo Therapeutics Holdings Corp Frequently Asked Questions
What is InVivo Therapeutics Holdings Corp(NVIVQ)'s stock price today?
The current price of NVIVQ is $0.37. The 52 week high of NVIVQ is $1.64 and 52 week low is $0.15.
When is next earnings date of InVivo Therapeutics Holdings Corp(NVIVQ)?
The next earnings date of InVivo Therapeutics Holdings Corp(NVIVQ) is .
Does InVivo Therapeutics Holdings Corp(NVIVQ) pay dividends? If so, how much?
InVivo Therapeutics Holdings Corp(NVIVQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers